This action of CHAC1, known as the “blocker of NOTCH,” effectively reduces the cell surface expression of the full-length NOTCH1 receptor, thus inhibiting the NOTCH1 signaling pathway and contributing to the suppression of T-ALL cell viability (Chang Soo et al., 2023). This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.